Y200-1713 Screening compound: 2-(3-bromophenyl)-N-(1,3,4-thiadiazol-2-yl)quinoline-4-carboxamide

Y200-1713 Screening compound: 2-(3-bromophenyl)-N-(1,3,4-thiadiazol-2-yl)quinoline-4-carboxamide
Y200-1713 Screening compound: 2-(3-bromophenyl)-N-(1,3,4-thiadiazol-2-yl)quinoline-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-1713
2-(3-bromophenyl)-N-(1,3,4-thiadiazol-2-yl)quinoline-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-1713

Molecular Formula

C18H11BrN4OS (C18 H11 BrN4 OS)

Compound Name

2-(3-bromophenyl)-N-(1,3,4-thiadiazol-2-yl)quinoline-4-carboxamide

IUPAC name

2-(3-bromophenyl)-N-(134-thiadiazol-2-yl)quinoline-4-carboxamide

SMILES

O=C(c1cc(-c2cccc(Br)c2)nc2ccccc12)Nc1nncs1

InChI

InChI=1S/C18H11BrN4OS/c19-12-5-3-4-11(8-12)16-9-14(13-6-1-2-7-15(13)21-16)17(24)22-18-23-20-10-25-18/h1-10H,(H,22,23,24)

InChI Key

UZPUNFHKMWXDPB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01343100

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

411.28

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.884

Distribution Coefficient, logD

4.881

Water Solubility, LogSw

-5.05

Polar Surface Area

54.964

Acid Dissociation Constant (pKa)

9.50

Base Dissociation Constant (pKb)

1.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

Y200-1713 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Aging Library (44940 compounds)

Antiviral Library (67538 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with Y200-1713 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-1713?
Check Price and Availability of Y200-1713, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-1713 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-1713
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-1713
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-1713 available by request